MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
2013 |
Industry |
Biotechnology |
Stock Exchange |
NYSESPB |
Shares |
443 M |
Market Cap[1] |
$ 36.3 B |
EBITDA (LTM) |
$ 154 M |
P/E (LTM) |
13.777778 |
P/S (LTM) |
3.822559 |
EPS (LTM) |
5.94 |
Zoetis is a global leader in animal health and veterinary medicine, providing a wide range of products and services to improve animal health, including medicines, vaccines, diagnostic tests, and animal health management programs. The company was created in 2013 after being spun off from Pfizer Inc., and is headquartered in New Jersey, USA.
Zoetis works with farmers, veterinarians, and other professionals in the livestock and animal health industries around the world. The company is committed to innovation and developing new products and services to improve animal health and provide more effective animal health management. Zoetis is also actively involved in social responsibility, supporting various charitable organizations and programs.
Today, Zoetis has a presence in over 100 countries and serves millions of animals. The company is constantly striving to improve its products and services to meet the needs of its customers and partners.
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Precigen
PGEN
|
$ 4.2 | -16.94 % | $ 1.31 B | Nasdaq Global Select Market | USA |
 |
Phio Pharmaceuticals Corp.
PHIO
|
$ 0.81 | -7.25 % | $ 4.85 M | Nasdaq Capital Market | USA |
 |
Praxis Precision Medicines
PRAX
|
$ 262.42 | -7.85 % | $ 5.91 B | Nasdaq Global Select Market,SPB | USA |
 |
Prelude Therapeutics Incorporated
PRLD
|
$ 3.55 | -12.99 % | $ 273 M | Nasdaq Global Select Market | USA |
 |
ProQR Therapeutics N.V.
PRQR
|
$ 1.34 | -5.32 % | $ 141 M | Nasdaq Global Market |  Niderland |
 |
Ocular Therapeutix
OCUL
|
$ 6.48 | -9.31 % | $ 1.21 B | Nasdaq Global Select Market | USA |
 |
PolyPid Ltd.
PYPD
|
$ 5.8 | -0.34 % | $ 94.8 M | Nasdaq Global Select Market |  Israel |
 |
Summit Therapeutics
SMMT
|
$ 14.17 | -12.37 % | $ 10.6 B | Nasdaq Global Select Market |  Britain |
 |
Outlook Therapeutics
OTLK
|
$ 0.44 | -4.63 % | $ 15.3 M | Nasdaq Global Select Market | USA |
 |
uniQure N.V.
QURE
|
$ 20.96 | -9.01 % | $ 1.21 B | Nasdaq Global Select Market | Niderland |
 |
Ultragenyx Pharmaceutical
RARE
|
$ 15.55 | -9.38 % | $ 1.53 B | Nasdaq Global Select Market,SPB | USA |
 |
Rafael Holdings
RFL
|
$ 1.06 | -4.5 % | $ 54.5 M | NYSE | USA |
 |
REGENXBIO
RGNX
|
$ 7.37 | -4.47 % | $ 380 M | Nasdaq Global Select Market,SPB | USA |
 |
Sanofi
SNY
|
$ 46.87 | -1.26 % | $ 57.2 B | Nasdaq Global Select Market |  France |
 |
Rigel Pharmaceuticals
RIGL
|
$ 45.56 | -11.17 % | $ 819 M | Nasdaq Global Select Market | USA |
 |
Celsion Corporation
CLSN
|
- | -6.63 % | $ 13.9 M | Nasdaq Capital Market | USA |
 |
Генетико
GECO
|
- | - | - | MOEX |  Russia |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
Tenax Therapeutics
TENX
|
$ 1.65 | -8.84 % | $ 64.7 M | Nasdaq Global Select Market | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market | France |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market | France |
 |
Scholar Rock Holding Corporation
SRRK
|
$ 45.27 | -1.78 % | $ 5.19 B | Nasdaq Global Select Market | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market |  Germany |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
- | 0.74 % | $ 768 M | Nasdaq Capital Market | Israel |
 |
Abcam plc
ABCM
|
- | - | $ 4.9 B | Nasdaq Global Select Market | Britain |
 |
Rezolute
RZLT
|
$ 3.65 | -7.95 % | $ 379 M | Nasdaq Capital Market | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market | Britain |
 |
Tiziana Life Sciences PLC
TLSA
|
$ 0.62 | -2.71 % | $ 66.1 M | Nasdaq Global Market | Britain |
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market | Germany |
 |
Affimed N.V.
AFMD
|
- | -34.95 % | $ 21.5 M | Nasdaq Global Select Market,SPB | Germany |
 |
XTL Biopharmaceuticals Ltd.
XTLB
|
$ 1.72 | 1.04 % | $ 1.16 B | Nasdaq Capital Market | Israel |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
- | -1.58 % | $ 28.1 M | Nasdaq Global Market | China |
 |
Celyad Oncology SA
CYAD
|
- | - | $ 12.5 M | Nasdaq Global Market |  Belgium |
 |
Seer
SEER
|
$ 1.63 | -4.12 % | $ 90.3 M | Nasdaq Global Select Market | USA |
 |
Gracell Biotechnologies
GRCL
|
- | - | $ 3.37 B | Nasdaq Global Select Market | China |
 |
Trevi Therapeutics
TRVI
|
$ 12.8 | -8.47 % | $ 1.72 B | Nasdaq Global Market | USA |
|
Silence Therapeutics plc
SLN
|
$ 19.73 | -0.35 % | $ 2.8 B | Nasdaq Global Select Market | Britain |
 |
Soligenix
SNGX
|
$ 0.33 | -5.02 % | $ 1.71 M | Nasdaq Capital Market | USA |
 |
Spruce Biosciences
SPRB
|
$ 42.5 | -8.82 % | $ 32.6 M | Nasdaq Global Select Market | USA |
 |
Supernus Pharmaceuticals
SUPN
|
$ 26.77 | -5.1 % | $ 1.51 B | Nasdaq Global Select Market,SPB | USA |
 |
Galapagos NV
GLPG
|
- | - | $ 1.83 B | Nasdaq Global Select Market | Belgium |
 |
Savara
SVRA
|
$ 4.33 | -7.06 % | $ 963 M | Nasdaq Global Select Market | USA |
 |
Teligent, Inc.
TLGT
|
- | -13.85 % | $ 16.1 M | Nasdaq Global Select Market | USA |
 |
Viela Bio, Inc.
VIE
|
- | - | $ 2.91 B | Nasdaq Global Select Market | USA |
 |
Gilead Sciences
GILD
|
$ 167.62 | -3.93 % | $ 209 B | Nasdaq Global Select Market,SPB | USA |
 |
TG Therapeutics
TGTX
|
$ 58.02 | -5.86 % | $ 8.37 B | Nasdaq Capital Market | USA |
 |
Vir Biotechnology
VIR
|
$ 11.01 | -6.5 % | $ 1.53 B | Nasdaq Global Select Market,SPB | USA |
 |
VistaGen Therapeutics
VTGN
|
$ 0.17 | -10.2 % | $ 6.47 M | Nasdaq Global Select Market | USA |
 |
Vanda Pharmaceuticals
VNDA
|
$ 3.6 | -7.22 % | $ 212 M | Nasdaq Global Select Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.